Sondel PM - Search Results

1

Severe combined immunodeficiency, interleukin-2 (IL-2), and the IL-2 receptor: experiments of nature continue to point the way.

Voss SD, Hong R, Sondel PM. Voss SD, et al. Among authors: sondel pm. Blood. 1994 Feb 1;83(3):626-35. Blood. 1994. PMID: 8298124 Free article. Review.

2

Characterization of the interleukin 2 receptors (IL-2R) expressed on human natural killer cells activated in vivo by IL-2: association of the p64 IL-2R gamma chain with the IL-2R beta chain in functional intermediate-affinity IL-2R.

Voss SD, Sondel PM, Robb RJ. Voss SD, et al. Among authors: sondel pm. J Exp Med. 1992 Aug 1;176(2):531-41. doi: 10.1084/jem.176.2.531. J Exp Med. 1992. PMID: 1500859 Free PMC article.

3

Serum CD25 levels during interleukin-2 therapy: dose dependence and correlations with clinical toxicity and lymphocyte surface sCD25 expression.

Bogner MP, Voss SD, Bechhofer R, Hank JA, Roper M, Poplack D, Hammond D, Sondel PM. Bogner MP, et al. Among authors: sondel pm. J Immunother (1991). 1992 Feb;11(2):111-8. J Immunother (1991). 1992. PMID: 1571333

4

Natural killer cells activated by interleukin 2 treatment in vivo respond to interleukin 2 primarily through the p75 receptor and maintain the p55 (TAC) negative phenotype.

Weil-Hillman G, Voss SD, Fisch P, Schell K, Hank JA, Sosman JA, Sugamura K, Sondel PM. Weil-Hillman G, et al. Among authors: sondel pm. Cancer Res. 1990 May 1;50(9):2683-91. Cancer Res. 1990. PMID: 1691679

5

Specific recognition of human leukemic cells by allogeneic T cells: II. Evidence for HLA-D restricted determinants on leukemic cells that are crossreactive with determinants present on unrelated nonleukemic cells.

Sosman JA, Oettel KR, Smith SD, Hank JA, Fisch P, Sondel PM. Sosman JA, et al. Among authors: sondel pm. Blood. 1990 May 15;75(10):2005-16. Blood. 1990. PMID: 1692492 Free article.

6

Increased expression of the interleukin 2 (IL-2) receptor beta chain (p70) on CD56+ natural killer cells after in vivo IL-2 therapy: p70 expression does not alone predict the level of intermediate affinity IL-2 binding.

Voss SD, Robb RJ, Weil-Hillman G, Hank JA, Sugamura K, Tsudo M, Sondel PM. Voss SD, et al. Among authors: sondel pm. J Exp Med. 1990 Oct 1;172(4):1101-14. doi: 10.1084/jem.172.4.1101. J Exp Med. 1990. PMID: 1698909 Free PMC article.

7

Interleukin-2: prospects for lymphocyte-mediated destruction of pediatric malignancies.

Sondel PM. Sondel PM. J Pediatr. 1991 Mar;118(3):S14-6. doi: 10.1016/s0022-3476(05)82184-5. J Pediatr. 1991. PMID: 1825672 Review.

8

Prospects for interleukin-2 therapy in hematologic malignant neoplasms.

Malkovska V, Sondel PM. Malkovska V, et al. Among authors: sondel pm. J Natl Cancer Inst Monogr. 1990;(10):69-72. J Natl Cancer Inst Monogr. 1990. PMID: 2189478 Review.

9

Graft-versus-leukemia reactions after bone marrow transplantation.

Horowitz MM, Gale RP, Sondel PM, Goldman JM, Kersey J, Kolb HJ, Rimm AA, Ringdén O, Rozman C, Speck B, et al. Horowitz MM, et al. Among authors: sondel pm. Blood. 1990 Feb 1;75(3):555-62. Blood. 1990. PMID: 2297567 Free article.

10

Antigen-specific recognition of autologous leukemia cells and allogeneic class-I MHC antigens by IL-2-activated cytotoxic T cells from a patient with acute T-cell leukemia.

Fisch P, Weil-Hillman G, Uppenkamp M, Hank JA, Chen BP, Sosman JA, Bridges A, Colamonici OR, Sondel PM. Fisch P, et al. Among authors: sondel pm. Blood. 1989 Jul;74(1):343-53. Blood. 1989. PMID: 2546621 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

382 results

Search Page

Filters